April 19, 2017: Abbott Laboratories reports Q1 EPS of $0.48 versus the $0.43 estimate. Revenue also beat coming in at $6.34 billion versus the $6.11 billion estimate.
The CEO Miles D. White said, “Our first quarter results reflect a strong start to the year. The integration of St. Jude is going well and recently (Read More….)
Overnight Analyst Actions:
MBLY Buy Jefferies & Company Inc
Overnight Headlines By Ticker:
ABT Abbott Laboratories
1/12 16:00 Announces US Launch and First Commercial Use of the New EnSite™ Precision Cardiac Mapping System
BIIB Biogen, Inc.
1/13 07:30 New data show SPINRAZA (nusinersen) significantly (Read More….)